| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e264b6682634fa0342d4d8ea4a8775f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_804bdb70a4328955c9f3a8daa746cbde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b151bb1090d57b436c67cfb2c9dc0507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_543f2d08abc9d1688c8e4a1dde9c5850 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07058efa5e79ee447809987ce62c652a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26f253c973766cbd0c621f7076c05433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13f9d889c1e489f715a68355aabfd33b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09bb948447006ad659a5c9a64c93932c |
| publicationDate |
2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013136742-A1 |
| titleOfInvention |
Peptide having cell membrane penetrating activity |
| abstract |
Provided are transmembrane complexes that contain a protein transduction domain (PTD) from the N-terminus of IgE-dependent histamine-releasing factor (HRF) and a target substance that is to be delivered into a cell. Also provided are nucleic acid molecules encoding the transmembrane complex, and methods of delivering the target substance into a cell interior by contacting the transmembrane complex with a cell. Also provided are transfection kits containing the PTD and the target substance. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9907857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10208323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10208324-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10731188-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019090390-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10918727-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3440096-A4 |
| priorityDate |
2006-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |